{"id":"W1991758119","doi":"10.1007/s00262-005-0010-0","title":"Monoclonal antibody therapy of chronic lymphocytic leukemia","year":2005,"lang":"en","type":"review","venue":"Cancer Immunology Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"Alemtuzumab; Chronic lymphocytic leukemia; Rituximab; Medicine; Fludarabine; Monoclonal antibody; Monoclonal antibody therapy; Immunology; Chemotherapy; Oncology; Leukemia; Antibody; Cancer research; Internal medicine; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006466158,0.0009437428,0.001745213,0.001832482,0.0002490105,0.0007241888,0.0009833664,0.0009828981,0.002514972],"category_scores_gemma":[0.000697419,0.0002442153,0.000523459,0.001656827,0.0003898937,0.0008814461,0.0004735734,0.001726649,0.001482618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006669775,"about_ca_system_score_gemma":0.0007955332,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001381455,"about_ca_topic_score_gemma":0.003029082,"domain_scores_codex":[0.9998418,0.00003451283,0.00002262043,0.00002473474,0.00005712475,0.00001918217],"domain_scores_gemma":[0.9997733,0.0001082044,0.00003783693,0.000006180521,0.00005278387,0.00002173901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001778018,0.0001014839,0.0001309439,0.009445126,0.0001103952,0.0002274037,0.00002460543,0.0003357735,0.001326587,0.001937647,0.04024603,0.9459361],"study_design_scores_gemma":[0.0001226924,0.0001781968,0.0006105599,0.002438052,0.0001968642,0.00113456,0.00002371584,0.00009186364,0.000409364,0.0008125898,0.9939691,0.00001242943],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009668821,0.9986406,0.00009575461,0.0001597403,0.0002689829,0.000005502368,0.000008991913,0.000005002014,0.0007187914],"genre_scores_gemma":[0.000790743,0.9977678,0.0001622703,0.0003150342,0.000229634,0.000007702547,0.00002728215,0.000001040779,0.0006984985],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002514972,"threshold_uncertainty_score":0.008413374,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06360689097298267,"score_gpt":0.4219103626378996,"score_spread":0.3583034716649169,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}